Purpose: To determine predictors for missing trifecta in patients who underwent flexible ureteroscopy (FURS) for treatment of renal and upper ureteric calculi.
Patients And Methods: The data of adult patients with renal or upper ureteral stones who underwent FURS from June 2021 through December 2022 were retrospectively reviewed. Stone-free status (no residual stones > 3 mm) was evaluated after 3 months with non-contrast CT. Modified Clavien classification was used to grade complications. A stone-free status after a single intervention of FURS without complications was defined as trifecta. Patients were divided into two groups (trifecta and non-trifecta). Risk factors for missing trifecta were compared between both groups using univariate and multivariate analyses.
Results: Three hundred twenty-three patients with mean age 48.9 ± 13 years and mean stone length 16 ± 5.9 mm were included. The trifecta criteria were applicable for 250 patients (71%). On multivariate analysis, risk factors for missing trifecta were stone multiplicity (OR: 3.326, 95%CI: 1.933-5.725) and non-experienced surgeons (OR: 1.819, 95%CI: 1.027-3.220).
Conclusions: Multiple stones and performance of FURS by non-experienced surgeons are the independent risk factors for missing trifecta of FURS.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11136456 | PMC |
| http://dx.doi.org/10.1080/20905998.2024.2325784 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The current role of pentafecta in the reporting of radical cystectomy outcomes: a scoping review.
Transl Androl Urol
June 2024
Department of Urology, University Hospital Essen, Essen, Germany.
Article Synopsis
- - The study reviews the "pentafecta" criteria for reporting outcomes following radical cystectomy (RC), originally encompassing five specific health measures; it has since been modified to focus more on complications and cancer recurrence.
- - A total of 12 studies involving nearly 5,000 patients were analyzed, revealing that only 34% achieved all pentafecta goals, with major complications and insufficient lymph node removal being significant barriers.
- - The research indicates that achieving pentafecta is linked to better long-term cancer outcomes and quality of life, but limitations include the retrospective nature of studies and generally short follow-up periods.
Trifecta in flexible ureteroscopy for treatment of renal and upper ureteral calculi: A multicenter study.
Arab J Urol
March 2024
Department of Urology, Urology and Nephrology Center, Mansoura University, Mansoura, Egypt.
Purpose: To determine predictors for missing trifecta in patients who underwent flexible ureteroscopy (FURS) for treatment of renal and upper ureteric calculi.
Patients And Methods: The data of adult patients with renal or upper ureteral stones who underwent FURS from June 2021 through December 2022 were retrospectively reviewed. Stone-free status (no residual stones > 3 mm) was evaluated after 3 months with non-contrast CT.
Definition and Unfavorable Risk Factors of Trifecta in Mini-Percutaneous Nephrolithotomy.
J Endourol
August 2021
Urology Unit, AL-Amiri Hospital, Kuwait, Kuwait.
In performing mini-percutaneous nephrolithotomy (PCNL), we aimed at achieving the trifecta of stone-free status and no complications in a single treatment session. We analyzed our experience to determine negative predictors for achieving these three-fold goals. The data of all consecutive patients who underwent tubeless mini-PCNL between July 2015 and March 2020 in two hospitals were retrospectively reviewed.
View Article and Find Full Text PDFXanthogranulomatous prostatitis (XGP) is a rare disease that can mimic the clinical and imaging findings of prostate cancer. Differentiation of these diseases is vital in order to offer the correct treatment. Histological examination of prostate tissue is the definitive manner in which XGP is distinguished from prostate cancer.
View Article and Find Full Text PDFReporting combined outcomes with Trifecta and survival, continence, and potency (SCP) classification in 337 patients with prostate cancer treated with image-guided hypofractionated radiotherapy.
BJU Int
December 2014
Department of Radiation Oncology, the Epidemiology and Biostatistics of the European Institute of Oncology, Milan, Italy.
Objective: To report the image-guided hypofractionated radiotherapy (hypo-IGRT) outcome for patients with localised prostate cancer according to the new outcome models Trifecta (cancer control, urinary continence, and sexual potency) and SCP (failure-free survival, continence and potency).
Patients And Methods: Between August 2006 and January 2011, 337 patients with cT1-T2N0M0 prostate cancer (median age 73 years) were eligible for a prospective longitudinal study on hypo-IGRT (70.2 Gy/26 fractions) in our Department.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!